Laboratoires Thea

This study tests an experimental drug called sepofarsen in people with a rare genetic eye disease (LCA10) that causes severe vision loss from childhood. The drug is injected into one eye, while the other eye gets a placebo, to see if it can improve vision safely. About 32 partici…

This study tests a drug called ultevursen in 81 people with retinitis pigmentosa caused by a specific gene change (USH2A). The drug is injected into the eye and compared to a sham injection. The goal is to see if it can slow the loss of vision over two years. Participants must be…

This study tests whether T10430 eye drops can safely slow or stop the worsening of nearsightedness (myopia) in children aged 6 to 12. Myopia happens when the eye grows too long, causing blurry distance vision and raising the risk of serious eye problems later. The trial will enro…

This study compares a new eye drop (T1695) to an existing one (ciclosporin) for children aged 4 to 17 with moderate to severe vernal keratoconjunctivitis, a serious eye allergy. The goal is to see which treatment better reduces eye surface damage and is safer. About 120 participa…

This study is testing a new eye drop (T2769) that contains trehalose, sodium hyaluronate, and NAAGA to see if it can improve dry eye symptoms and quality of life. Thirty adults with dry eye disease will use the drops daily for 6 months. The study will measure changes in symptoms …

This study tests whether a new preservative-free eyelid cream helps people feel more comfortable after eyelid surgery (like blepharoplasty or ptosis repair). About 30 adults will use the cream twice a day for 3 months. Researchers will measure how satisfied patients are with thei…

This study is testing a smart device called CONNECTDROP® that clips onto glaucoma eye drop bottles to track how often patients take their medication. Researchers want to see if using this device helps patients follow their prescribed treatment plan. About 200 adults with glaucoma…